GuideWell and Highmark Ventures Lead $35 Million Funding Round in Kidney Health Leader Healthmap Solutions
Retrieved on:
Monday, May 2, 2022
D, Blue Cross Blue Shield Association, Nephrology, Medicare, Acos, Highmark, Windrose, CKD, Cardiology, GLOBE, Kidney disease, DCHP, NCQA, Physician, Patient, Commercial, Partnership, 21st Century Cures Act, Renal replacement therapy, Family, Hospital, Health, Medicaid, Blue, Advancing American Kidney Health, Accountable care organization, Public health, Research, Allegheny Health Network, Triple-S Management Corporation, American Association of Clinical Endocrinologists, Health insurance, Pharmaceutical industry, Risk management, GuideWell
TAMPA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- GuideWell and Highmark Ventures lead a $35 million funding round for kidney health leader Healthmap Solutions (Healthmap), a leading NCQA accredited kidney population health management company.
Key Points:
- TAMPA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- GuideWell and Highmark Ventures lead a $35 million funding round for kidney health leader Healthmap Solutions (Healthmap), a leading NCQA accredited kidney population health management company.
- For this reason, Healthmap has built a Kidney Health Management solution to be used with our clients to deliver clinical, financial, and operational excellence.
- Reimer added that GuideWell and Highmark Inc., who are both customers of Healthmap, conducted a comprehensive review of the kidney management market before selecting Healthmap as a partner, and later chose to invest in Healthmap.
- Healthmap Solutions is an NCQA accredited kidney population health management company serving health plans, health systems, accountable care organizations (ACOs), and provider groups seeking a value-based solution to improve the lives of millions of Americans living with kidney disease.